Other relevant device(s) are: product id: 977a275, serial/lot #: (b)(4), ubd: 26-oct-2021, udi#: (b)(4); product id: 977a275, serial/lot #: (b)(4), ubd: 26-oct-2021, udi#: (b)(4).
The following products are reported in a separate regulatory report.
See report #3004209178-2021-06703.
Product id: 977a275, serial#: (b)(4), implanted: (b)(6) 2017, product type: lead.
Product id: 977a275, serial#: (b)(4), implanted: (b)(6) 2017, product type: lead.
Product id: 97715, serial#: (b)(4), implanted: (b)(6) 2017, product type: implantable neurostimulator.
If information is provided in the future, a supplemental report will be issued.
|
Information was received from a patient via a manufacturer representative (rep) regarding a patient who was implanted with an implantable neurostimulator (ins) for non-malignant pain.
It was reported that the patient has two systems implanted, cervical and thoracic.
The patient stated hat her cervical implant has always caused her issues, specifically burning in her throat.
She also reports having 4 grand mal seizures post nuss procedure.
They believe this was caused by a new medication initiated post-procedure.
The cervical was done after her seizures which shows electrodes on both leads that appear to be fractured.
The rep attached an image for reference.
The cervical ins was dead at the time of the report.
The rep was unsure if the cervical lead issue happened before or after seizures but imaging post-seizure did show what appeared to be fractured leads.
The patient wanted to have the cervical system explanted so they are planning to do that.
Surgery was scheduled for (b)(6) 2021.
The issue was not resolved at the time of the report.
|